Skip to main content
. 2019 Jun 10;179(8):1113–1121. doi: 10.1001/jamainternmed.2019.1201

Table 1. Baseline Characteristics of Study Participants.

Characteristic No. (%) P Valuea
Total (n = 391) Control (n = 134) Intervention
All
(n = 257)
Home Based (n = 128) Clinic Based (n = 129)
Age, mean (SD) 67.8 (7.4) 68.4 (8.1) 67.3 (7.0) 68.1 (7.4) 66.5 (6.4) .18
Age, y .10
60-69 270 (69.1) 88 (65.7) 182 (70.8) 84 (65.6) 98 (76.0)
70-79 83 (21.2) 27 (20.2) 56 (21.8) 32 (25.0) 24 (18.6)
≥80 38 (9.7) 19 (14.2) 9 (7.4) 12 (9.4) 7 (5.4)
Male sex 58 (15.1) 17 (12.7) 41 (16.0) 19 (14.8) 22 (17.1) .39
Race/ethnicity .42
White, non-Hispanic 29 (7.4) 6 (4.5) 23 (9.0) 12 (9.4) 11 (8.5)
Black, non-Hispanic 119 (30.4) 43 (32.1) 76 (29.6) 37 (28.9) 39 (30.2)
Hispanic 220 (56.3) 76 (56.7) 144 (56.0) 74 (57.8) 70 (54.3)
Other 23 (5.9) 9 (6.7) 14 (5.5) 5 (3.9) 9 (7.0)
Limited English proficiency 144 (36.8) 52 (38.8) 92 (35.8) 49 (38.3) 43 (33.3) .83
Monthly household income <$1350 262 (67.0) 86 (64.2) 176 (68.5) 87 (68.0) 89 (69.0) .39
Married or partner 94 (24.0) 39 (29.1) 55 (21.4) 33 (25.8) 22 (17.1) .09
Education .09
<High school 163 (41.7) 63 (47.0) 100 (38.9) 50 (39.1) 50 (38.8)
High school graduate 82 (21.0) 27 (20.2) 55 (21.4) 31 (24.2) 24 (18.6)
Some college 84 (21.5) 31 (23.1) 53 (20.6) 25 (19.5) 28 (21.7)
College graduate 62 (15.9) 13 (9.7) 49 (19.1) 22 (17.2) 27 (20.9)
Physical impairment, severe 58 (14.8) 22 (16.4) 36 (14.0) 16 (12.5) 20 (15.5) .52
Cognitive impairment 204 (52.2) 75 (56.0) 129 (50.2) 63 (49.2) 66 (51.2) .28
Moderate-severe depression 32 (8.4) 10 (7.8) 22 (8.7) 12 (9.6) 10 (7.9) .76
Comorbid medical conditions
Diabetes mellitus 153 (39.1) 52 (38.8) 101 (39.3) 44 (34.4) 57 (44.2) .92
High cholesterol 210 (53.7) 74 (55.2) 136 (52.9) 70 (54.7) 66 (51.2) .66
Hypertension 283 (72.4) 106 (79.1) 177 (68.9) 88 (68.8) 89 (69.0) .03
Main outcomes
ACT score, mean (SD) 14.6 (4.0) 14.3 (4.0) 14.8 (3.9) 15.0 (3.8) 14.6 (4.0) .25
mAQLQ score, mean (SD) 4.4 (1.1) 4.3 (1.1) 4.4 (1.2) 4.4 (1.2) 4.4 (1.2) .78
Patients with ≥1 hospitalization prior 12 mo 6 (1.5) 3 (2.2) 4.4 (1.2) 0 3 (2.3) .42b
Patients with ≥1 ED visit prior 12 mo 40 (10.2) 13 (9.7) 27 (10.5) 17 (13.3) 10 (7.8) .86b
Medication Adherence Ratings scale score, mean (SD) 3.7 (0.7) 3.8 (0.7) 3.6 (0.7) 3.6 (0.7) 3.7 (0.6) .11
MDI technique,c % correctly completed steps, median (range) 60 (0-100) 64 (9-100) 56 (0-100) 60 (0-100) 55 (0-100) .10

Abbreviations: ACT, Asthma Control Test; ED, emergency department; mAQLQ, Mini Asthma Quality of Life Questionnaire; MDI, metered-dose inhaler.

a

Intervention vs control.

b

Fisher exact test.

c

n = 355.